documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
85 rows where docket_id = "FDA-1975-N-0012" and posted_year = 2016 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 74
- Other 10
- Rule 1
posted_year 1
- 2016 · 85 ✖
agency_id 1
- FDA 85
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0012-0723 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Response Letter from American Cleaning Institute (ACI) | Other | Letter(s) | 2016-12-12T05:00:00Z | 2016 | 12 | 2016-12-12T05:00:00Z | 2016-12-12T21:52:28Z | 0 | 0 | 09000064823fcc03 | ||
| FDA-1975-N-0012-0722 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Draft Protocol Study from American Cleaning Institute | Supporting & Related Material | Background Material | 2016-11-25T05:00:00Z | 2016 | 11 | 2016-11-25T14:19:32Z | 0 | 0 | 09000064823be604 | |||
| FDA-1975-N-0012-0710 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 58 Infections and Pseudoinfections Due to Povidone-Iodine Solution Contaminated with Pseudomonas cepacia re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:20Z | 0 | 0 | 09000064821bfd1d | |||
| FDA-1975-N-0012-0652 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | List of References re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:48:25Z | 0 | 0 | 09000064821bfa64 | |||
| FDA-1975-N-0012-0657 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 5 Minutes_of_Meeting,_11_14_2008 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:39Z | 0 | 0 | 09000064821bfaa7 | |||
| FDA-1975-N-0012-0670 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 18 Involvement of efflux mechanisms in biocide resistance of Campylobacter jejuni and Campylobacter coli re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:40Z | 0 | 0 | 09000064821bfafe | |||
| FDA-1975-N-0012-0683 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 31 Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:36Z | 0 | 0 | 09000064821bfb07 | |||
| FDA-1975-N-0012-0690 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 38 Use of antibacterial consumer products containing quaternary ammonium compounds and drug resistance in the community re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:02Z | 0 | 0 | 09000064821bfb1e | |||
| FDA-1975-N-0012-0694 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 42 Cross-resistance to antibiotics of Escherichia coli adapted to benzalkonium chloride or exposed to stress-inducers re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:42Z | 0 | 0 | 09000064821bfb22 | |||
| FDA-1975-N-0012-0696 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 44 Adaptive resistance to benzalkonium chloride, amikacin and tobramycin: the effect on susceptibility to other antimicrobials re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:32Z | 0 | 0 | 09000064821bfb24 | |||
| FDA-1975-N-0012-0700 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 48 330TOXICOLOGY AND CARCINOGENESISSTUDIES OF4-HEXYLRESORCINOL(CAS NO. 136-77-6)IN F344/N RATS AND B6C3Fi MICE(GAVAGE STUDIES) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:14Z | 0 | 0 | 09000064821bfb2c | |||
| FDA-1975-N-0012-0716 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 64 NTP Research Concept: Triclocarban re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:49Z | 0 | 0 | 09000064821bfb51 | |||
| FDA-1975-N-0012-0721 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 70 SCCS final Opinion on triclosan June 2010 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:25Z | 0 | 0 | 09000064821bfb58 | |||
| FDA-1975-N-0012-0653 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 1 Transcript of Jan 22 1997 Joint Meeting re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:48:20Z | 0 | 0 | 09000064821bfa65 | |||
| FDA-1975-N-0012-0661 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 9 Effect of Antibacterial Home Cleaning and Handwashing Products on Infectious Disease Symptoms re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:22Z | 0 | 0 | 09000064821bfaf5 | |||
| FDA-1975-N-0012-0662 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 10 Elimination of methicillin-resistant Siaphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:17Z | 0 | 0 | 09000064821bfaf6 | |||
| FDA-1975-N-0012-0663 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 11 Use of 0.3% triclosan (Bacti-Stat*) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:13Z | 0 | 0 | 09000064821bfaf7 | |||
| FDA-1975-N-0012-0669 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 17 Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:44Z | 0 | 0 | 09000064821bfafd | |||
| FDA-1975-N-0012-0681 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 29 Prevalence of decreased susceptibility to triclosan in Salmonella enterica isolates from animals and humans and association with multiple drug resistance re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:46Z | 0 | 0 | 09000064821bfb05 | |||
| FDA-1975-N-0012-0693 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 41 Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:48Z | 0 | 0 | 09000064821bfb21 | |||
| FDA-1975-N-0012-0714 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 62 Pseudobacteremia Caused by Povidone-Iodine Solution Contaminated with Pseudomonas Cepacia re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:00Z | 0 | 0 | 09000064821bfd21 | |||
| FDA-1975-N-0012-0715 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 63 Triclocarban_HPV_Robust_Study_Summaries re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:54Z | 0 | 0 | 09000064821bfd22 | |||
| FDA-1975-N-0012-0675 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 23 Triclosan Can Select for an AdeIJK-Overexpressing Mutant of Acinetobacter baumannii ATCC 17978 That Displays Reduced Susceptibility to Multiple Antibiotics re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:16Z | 0 | 0 | 09000064821bf8f6 | |||
| FDA-1975-N-0012-0658 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 6 NDAC 2014 Transcript re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:34Z | 0 | 0 | 09000064821bfaa8 | |||
| FDA-1975-N-0012-0664 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 12 Quantitative Microbial Risk Assessment of Antibacterial Hand Hygiene Products on Risk of Shigellosis re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:09Z | 0 | 0 | 09000064821bfaf8 | |||
| FDA-1975-N-0012-0688 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 36 Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:13Z | 0 | 0 | 09000064821bfb0d | |||
| FDA-1975-N-0012-0702 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 50 Antimicrobial Effectiveness of Povidone-Iodine and Consequences for New Application Areas. re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:59Z | 0 | 0 | 09000064821bfb2e | |||
| FDA-1975-N-0012-0706 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 54 Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:39Z | 0 | 0 | 09000064821bfd19 | |||
| FDA-1975-N-0012-0707 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 55 Iodine and Iodine Compounds re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:35Z | 0 | 0 | 09000064821bfd1a | |||
| FDA-1975-N-0012-0667 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 15 Statistical, Epidemiological, and Risk-Assessment Approaches to Evaluating Safety of Vaccines Throughout the Life Cycle at the Food and Drug Administration re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:53Z | 0 | 0 | 09000064821bfafb | |||
| FDA-1975-N-0012-0651 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Rule | Final Rule | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T04:00:00Z | 2019-04-04T03:59:59Z | 2019-04-03T01:05:19Z | 2016-21337 | 0 | 0 | 09000064821d2e5a |
| FDA-1975-N-0012-0678 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 26 Resistant Mechanism Study of Benzalkonium Chloride Selected Salmonella Typhimurium Mutants re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:00Z | 0 | 0 | 09000064821bf8f9 | |||
| FDA-1975-N-0012-0660 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 8 Effect of handwashing on child health: a randomised controlled trial re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:26Z | 0 | 0 | 09000064821bfaaf | |||
| FDA-1975-N-0012-0686 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 34 Relationship between Triclosan and Susceptibilities of Bacteria Isolated from Hands in the Community re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:22Z | 0 | 0 | 09000064821bfb0a | |||
| FDA-1975-N-0012-0692 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 40 Adaptive Resistance to Biocides in Salmonella enterica and Escherichia coli O157 and Cross-Resistance to Antimicrobial Agents re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:53Z | 0 | 0 | 09000064821bfb20 | |||
| FDA-1975-N-0012-0704 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 52 Povidone Iodine re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:49Z | 0 | 0 | 09000064821bfb33 | |||
| FDA-1975-N-0012-0705 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 53 Antiseptic Efficacy of Disinfecting Solutions in Suspension Test in vitro against Methicillin-Resistant Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in Pressure Sore Wounds after Spinal Cord Injury re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:45Z | 0 | 0 | 09000064821bfb34 | |||
| FDA-1975-N-0012-0720 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 69 Short-term in vivo exposure to the water contaminant triclosan: Evidence for disruption of thyroxine re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:31Z | 0 | 0 | 09000064821bfb57 | |||
| FDA-1975-N-0012-0673 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 21 Salmonella enterica serovar Typhimurium multidrug efflux pumps EmrAB and AcrEF support the major efflux system AcrAB in decreased susceptibility to triclosan re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:26Z | 0 | 0 | 09000064821bf8f4 | |||
| FDA-1975-N-0012-0689 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 37 The Frequency of Antibiotic-Resistant Bacteria in Homes Differing in Their Use of Surface Antibacterial Agents re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:07Z | 0 | 0 | 09000064821bfb0e | |||
| FDA-1975-N-0012-0697 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 45 ICH HARMONISED TRIPARTITE GUIDELINE TESTING FOR CARCINOGENICITY OF PHARMACEUTICALS S1B Current Step 4 version dated 16 July 1997 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:28Z | 0 | 0 | 09000064821bfb25 | |||
| FDA-1975-N-0012-0698 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 46 Guidance for Industry S1B Testing for Carcinogenicity of Pharmaceuticals re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:24Z | 0 | 0 | 09000064821bfb27 | |||
| FDA-1975-N-0012-0703 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 51 Povidone–iodine: use in hand disinfection, skin preparation and antiseptic irrigation re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:54Z | 0 | 0 | 09000064821bfb32 | |||
| FDA-1975-N-0012-0676 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 24 Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:12Z | 0 | 0 | 09000064821bf8f7 | |||
| FDA-1975-N-0012-0684 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 32 Chloroxylenol- and triclosan-tolerant bacteria from industrial sources—susceptibility to antibiotics and other biocides re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:32Z | 0 | 0 | 09000064821bfb08 | |||
| FDA-1975-N-0012-0717 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 65 Scientific Committee on Consumer Products OPINION ON Dermal Sensitisation Quantitative Risk Assessment (Citral, Farnesol and Phenylacetaldehyde) re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:45Z | 0 | 0 | 09000064821bfb52 | |||
| FDA-1975-N-0012-0718 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 66 Newsletter of the European Commission Scientific Committees June 2011 en re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:40Z | 0 | 0 | 09000064821bfb55 | |||
| FDA-1975-N-0012-0712 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 60 CDC Contaminated Povidone-Iodine Solution -- Texas re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:10Z | 0 | 0 | 09000064821bfd1f | |||
| FDA-1975-N-0012-0713 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 61 Pseudobacteremia Attributed to Contamination of Povidone-Iodine with Psedomonas cepacia re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:04Z | 0 | 0 | 09000064821bfd20 | |||
| FDA-1975-N-0012-0655 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 3 NDAC March 2005 Transcript re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:48:08Z | 0 | 0 | 09000064821bfa69 | |||
| FDA-1975-N-0012-0656 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 4 NDAC October 2005 Transcript re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:45Z | 0 | 0 | 09000064821bfaa6 | |||
| FDA-1975-N-0012-0709 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 57 Drug Resistance Studies with Topical Antiseptics re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:25Z | 0 | 0 | 09000064821bfd1c | |||
| FDA-1975-N-0012-0666 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 14 Quanti cation and Variability Analysis of Bacterial Cross-Contamination Rates in Common Food Service Tasks re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:57Z | 0 | 0 | 09000064821bfafa | |||
| FDA-1975-N-0012-0668 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 16 Recent advances in the potential interconnection between antimicrobial resistance to biocides and antibiotics re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:48Z | 0 | 0 | 09000064821bfafc | |||
| FDA-1975-N-0012-0687 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 35 Antibacterial Cleaning Products and Drug Resistance re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:18Z | 0 | 0 | 09000064821bfb0b | |||
| FDA-1975-N-0012-0695 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 43 Development of triclosan and antibiotic resistance in Salmonella enterica serovar Typhimurium re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:37Z | 0 | 0 | 09000064821bfb23 | |||
| FDA-1975-N-0012-0699 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 47 Citizen_Petition_from_Comprehensive_Technology_Center re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:19Z | 0 | 0 | 09000064821bfb2b | |||
| FDA-1975-N-0012-0719 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 68 Absorption and Metabolism of Triclosan After Application to the Skin of B6C3F1 Mice re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:37:35Z | 0 | 0 | 09000064821bfb56 | |||
| FDA-1975-N-0012-0711 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 59 Nosocomial Outbreaks: The Centers for Disease Control’s Hospital Infections Program Experience, 1980-1990 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:15Z | 0 | 0 | 09000064821bfd1e | |||
| FDA-1975-N-0012-0672 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 20 Polymorphic Variation in Susceptibility and Metabolism of Triclosan-Resistant Mutants of Escherichia coli and Klebsiella pneumoniae Clinical Strains Obtained after Exposure to Biocides and Antibiotics re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:31Z | 0 | 0 | 09000064821bf8f3 | |||
| FDA-1975-N-0012-0674 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 22 Analysis of Triclosan-Selected Salmonella enterica Mutants of Eight Serovars Revealed Increased Aminoglycoside Susceptibility and Reduced Growth Rates re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:21Z | 0 | 0 | 09000064821bf8f5 | |||
| FDA-1975-N-0012-0677 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 25 Molecular mechanisms of higher MICs of antibiotics and quaternary ammonium compounds for Escherichia coli isolated from bacteraemia re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:07Z | 0 | 0 | 09000064821bf8f8 | |||
| FDA-1975-N-0012-0679 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 27 Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:55Z | 0 | 0 | 09000064821bf8fa | |||
| FDA-1975-N-0012-0654 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 2 Comment No FDA-1975-N-0012-0081 re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:48:15Z | 0 | 0 | 09000064821bfa68 | |||
| FDA-1975-N-0012-0701 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 49 Molecular Effects of Povidone-Iodine on RElevant Microorganisms: An Electron-Microscopic and Biochemical Study re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:05Z | 0 | 0 | 09000064821bfb2d | |||
| FDA-1975-N-0012-0708 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 56 Absence of bacterial resistance to povidone iodine re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:38:30Z | 0 | 0 | 09000064821bfd1b | |||
| FDA-1975-N-0012-0671 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 19 Development of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli adapted to biocides re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:41:35Z | 0 | 0 | 09000064821bf8f2 | |||
| FDA-1975-N-0012-0659 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 7 37 FR 9464, 1972, Part 130 Procedure for classification of OTC drugs re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:30Z | 0 | 0 | 09000064821bfaae | |||
| FDA-1975-N-0012-0680 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 28 Evaluation of Epidemiological Cut-Off Values Indicates that Biocide Resistant Subpopulations Are Uncommon in Natural Isolates of Clinically-Relevant Microorganisms re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:50Z | 0 | 0 | 09000064821bf8fb | |||
| FDA-1975-N-0012-0665 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 13 Quanti cation and Variability Analysis of Bacterial Cross-Contamination Rates in Common Food Service Tasks re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:42:04Z | 0 | 0 | 09000064821bfaf9 | |||
| FDA-1975-N-0012-0682 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 30 Staphylococcus epidermidis Isolated in 1965 Are More Susceptible to Triclosan than Current Isolates re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:41Z | 0 | 0 | 09000064821bfb06 | |||
| FDA-1975-N-0012-0685 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 33 Chloroxylenol- and triclosan-tolerant bacteria from industrial sources re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:40:27Z | 0 | 0 | 09000064821bfb09 | |||
| FDA-1975-N-0012-0691 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Reference 39 The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide Susceptibility in Staphylococcus aureus re Safety and Effectiveness of Consumer Antiseptics: Topical Antimicrobial Drug Products for Over-the-Counter Human Use | Supporting & Related Material | Background Material | 2016-09-06T04:00:00Z | 2016 | 9 | 2016-09-06T14:39:57Z | 0 | 0 | 09000064821bfb1f | |||
| FDA-1975-N-0012-0649 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from Lewis and Harrison (Lonza,Inc.) to FDA CDER | Other | Letter(s) | 2016-08-12T04:00:00Z | 2016 | 8 | 2016-08-12T04:00:00Z | 2016-08-12T19:29:47Z | 0 | 0 | 090000648217253d | ||
| FDA-1975-N-0012-0650 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Handwashing Habits Child Care Workers GLM 16123 National Online Study with Child Care Providers Conducted on Behalf of the American Cleaning Institute (April 2016) | Supporting & Related Material | Background Material | 2016-08-12T04:00:00Z | 2016 | 8 | 2016-08-12T19:41:45Z | 0 | 0 | 090000648217253c | |||
| FDA-1975-N-0012-0648 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Memorandum of Meeting Minutes Between FDA CDER and Lonza America, Inc | Other | Memorandum | 2016-06-28T04:00:00Z | 2016 | 6 | 2016-06-28T04:00:00Z | 2016-06-28T11:23:36Z | 0 | 0 | 0900006482073c0d | ||
| FDA-1975-N-0012-0647 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to Lonza America Inc. Re: Meeting Request Granted for May 25, 2016 | Other | Agency Response | 2016-05-18T04:00:00Z | 2016 | 5 | 2016-05-18T04:00:00Z | 2016-05-18T12:42:16Z | 0 | 0 | 0900006481fda242 | ||
| FDA-1975-N-0012-0646 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Response from American Cleaning Institute to FDA CDER (re: Benzalkonium Chloride) | Other | Response(s) | 2016-05-06T04:00:00Z | 2016 | 5 | 2016-05-06T04:00:00Z | 2016-05-06T18:40:24Z | 0 | 0 | 0900006481fb26e3 | ||
| FDA-1975-N-0012-0645 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Response from American Cleaning Institute to FDA CDER (re: Chloroxylenol) | Other | Response(s) | 2016-05-06T04:00:00Z | 2016 | 5 | 2016-05-06T04:00:00Z | 2016-05-06T18:36:11Z | 0 | 0 | 0900006481fb26e2 | ||
| FDA-1975-N-0012-0644 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Attachment 1 Agenda for Lonza-FDA Meeting re: Briefing Document from Lonza, Inc. (Lewis & Harrison) | Supporting & Related Material | Background Material | 2016-04-26T04:00:00Z | 2016 | 4 | 2016-04-26T19:31:34Z | 0 | 0 | 0900006481f8f9e8 | |||
| FDA-1975-N-0012-0643 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Draft Protocol for Hormonal Effects Studies: Uterotrophic Bioassay of Benzethonium Chloride USP by Oral (Gavage) in Female Rats re Comment from Lonza Inc, Lewis & Harrison | Supporting & Related Material | Background Material | 2016-03-22T04:00:00Z | 2016 | 3 | 2016-03-22T19:48:19Z | 0 | 0 | 0900006481983bed | |||
| FDA-1975-N-0012-0640 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to Lonza America, Inc., American Cleaning Institute and Henkel North America regarding Review of Benzethonium Chloride | Other | Letter(s) | 2016-03-10T05:00:00Z | 2016 | 3 | 2016-03-10T05:00:00Z | 2016-03-10T22:07:14Z | 0 | 0 | 0900006481ebae9d | ||
| FDA-1975-N-0012-0639 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to Lonza America, Inc., American Cleaning Institute and Henkel North America regarding Review of Benzalkonium Chloride | Other | Letter(s) | 2016-03-10T05:00:00Z | 2016 | 3 | 2016-03-10T05:00:00Z | 2016-03-10T22:04:06Z | 0 | 0 | 0900006481eba838 | ||
| FDA-1975-N-0012-0637 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Request from Henkel Consumer Goods, Inc. | Other | Request | 2016-03-10T05:00:00Z | 2016 | 3 | 2016-03-10T05:00:00Z | 2016-03-10T21:53:09Z | 0 | 0 | 0900006481d6ae19 | ||
| FDA-1975-N-0012-0638 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Letter from FDA CDER to American Cleaning Institute and Henkel North America regarding Review of Chloroxylenol | Other | Letter(s) | 2016-03-10T05:00:00Z | 2016 | 3 | 2016-03-10T05:00:00Z | 2016-03-10T22:01:29Z | 0 | 0 | 0900006481eba837 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);